Dorsey & Whitney Trust’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Hold
16,000
0.02% 482
2025
Q4
$408K Hold
16,000
0.02% 479
2025
Q3
$410K Hold
16,000
0.02% 472
2025
Q2
$405K Hold
16,000
0.02% 468
2025
Q1
$400K Hold
16,000
0.02% 450
2024
Q4
$393K Buy
+16,000
New +$400K 0.02% 446

Other funds holding IBDX

Dorsey & Whitney Trust's IBDX Position: Q1 2026 in Review

Dorsey & Whitney Trust held its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) position steady in Q1 2026 at 16,000 shares worth $404K. The position accounts for 0.02% of the portfolio, ranked #482.

Dorsey & Whitney Trust first reported a position in IBDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $410K in Q3 2025. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Dorsey & Whitney Trust held 16,000 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $404K as of Q1 2026.
  • Dorsey & Whitney Trust left its iShares iBonds Dec 2032 Term Corporate ETF share count unchanged in Q1 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.02% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #482 holding.
  • Dorsey & Whitney Trust first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2024 and has held it in 6 quarters since.
  • Dorsey & Whitney Trust's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $410K in Q3 2025.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.